Sarah Waheed

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Saad Z. Usmani, Christoph Heuck, Alyson E. Mitchell et al. · Haematologica · 2012 · 378 citations · Full text

Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

Bart Barlogie, Mauricio Pineda‐Roman, Frits van Rhee et al. · Blood · 2008 · 227 citations · Full text

Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance

Bijay Nair, Frits van Rhee, John D. Shaughnessy et al. · Blood · 2010 · 200 citations · Full text

Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

Saad Z. Usmani, Alan Mitchell, Sarah Waheed et al. · Blood · 2013 · 200 citations · Full text

High-risk myeloma is associated with global elevation of miRNAs and overexpression of <i>EIF2C2/AGO2</i>

Yiming Zhou, Lijuan Chen, Bart Barlogie et al. · Proceedings of the National Academy of Sciences · 2010 · 197 citations · Full text